Correlation between blood telomere length and CD4+ CD8+ T-cell subsets changes 96 weeks after initiation of antiretroviral therapy in HIV-1-positive individuals.
In 31 participants who started first-line antiretroviral therapy in the NEAT 001/ANRS 143 clinical trial, we found after 96 weeks a statistically significant increase in blood telomere length (TL) of 0.04 (T/S Ratio) (p = 0.03). This increase was positively correlated with both the change in the per...
Main Authors: | Mathieu Chalouni, Javier Rodriguez-Centeno, Assia Samri, Julian Blanco, Natalia Stella-Ascariz, Cedrick Wallet, Hernando Knobel, David Zucman, Belen Alejos Ferreras, Brigitte Autran, Rodolphe Thiebaut, François Raffi, Jose Ramon Arribas, NEAT 001/ANRS 143 Trial Study Group |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0230772 |
Similar Items
-
Body composition and adipokines changes after initial treatment with darunavir-ritonavir plus either raltegravir or tenofovir disoproxil fumarate-emtricitabine: A substudy of the NEAT001/ANRS143 randomised trial.
by: Jose I Bernardino, et al.
Published: (2019-01-01) -
CD96 targeted antibodies need not block CD96-CD155 interactions to promote NK cell anti-metastatic activity
by: Amelia Roman Aguilera, et al.
Published: (2018-05-01) -
BCL9 regulates CD226 and CD96 checkpoints in CD8+ T cells to improve PD-1 response in cancer
by: Mei Feng, et al.
Published: (2021-08-01) -
Coming of Age: CD96 Emerges as Modulator of Immune Responses
by: Hristo Georgiev, et al.
Published: (2018-05-01) -
CÃlulas CD3+, CD4+, CD8+, CD3-CD16+CD56+ e CD19+ em sangue perifÃrico de pacientes com hansenÃase e indivÃduos saudÃveis
by: CatiÃssia Dantas Pinheiro
Published: (2013)